MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
MSLE — Satellos Bioscience Inc. Common Stock
NasdaqSatellos Bioscience Inc. Common Stock
$7.54
-0.51(-6.34%)
- O
- 8.08
- H
- 8.38
- L
- 7.54
- V
- 47.52K
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About MSLE
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
IndustryCommon Stock
SectorNot available
IPO DateAug 18, 2021
Employees21
Stock ExchangeNasdaq
Ticker SymbolMSLE
Websitehttps://www.satellos.com
Key Financial Statistics
| Market Cap | $180.34M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $5.30 - $13.40 |
| 52-Week Avg Volume | 45.1K |
| VWAP | $7.86 |
| Transactions | 469 |
| Total Recorded Bars | 3,559 days |